Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: Surgical outcomes and learning curve analysisPedro F. Escobar, Luis Rojas-Espalliat, David Starks et al.|Gynecologic Oncology|2010Cited by 95
Results of a phase Ib trial evaluating the safety and clinical activity of sapanisertib (TAK 228) in combination with serabelisib (TAK 117) and paclitaxel in patients with advanced ovarian, endometrial, or breast cancer.Casey Williams, Luis Rojas‐Espaillat, Kirstin Williams et al.|Journal of Clinical Oncology|2020Cited by 9
Abstract 644: Validation of PD-L1 staining by IHC in solid tumors: A journey from xenograft model to ex vivo culture of clinical samplesXiaoqian Lin, Brian Leyland‐Jones, Jennifer Carlson et al.|Cancer Research|2018Cited by 0
Value of sequencing-guided treatment for patients with advanced malignancies.Casey Williams, Brian Leyland‐Jones, Robert B. Goldberg et al.|Journal of Clinical Oncology|2016Cited by 0
Symptoms and health related quality of life in patients receiving matched therapy.Kirstin Williams, Sandra Bergquist‐Beringer, Casey Williams et al.|Journal of Clinical Oncology|2017Cited by 0